Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial - Wikidata - awgldk - TriplyDB

Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial

Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial

http://www.wikidata.org/entity/Q35083803

about

Cardiac innervation and sudden cardiac death.Implantable neurotechnologies: a review of integrated circuit neural amplifiers Cardiac sympatho-vagal balance and ventricular arrhythmia Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine.Vagus nerve stimulation: An evolving adjunctive treatment for cardiac disease.Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.Cervical vagal nerve stimulation activates the stellate ganglion in ambulatory dogs.Vagal nerve stimulation started just prior to reperfusion limits infarct size and no-reflow Post-Exercise Heart Rate Recovery Independently Predicts Clinical Outcome in Patients with Acute Decompensated Heart Failure.Sensitivity Analysis of Vagus Nerve Stimulation Parameters on Acute Cardiac Autonomic Responses: Chronotropic, Inotropic and Dromotropic Effects.Autonomic Regulation Therapy in Heart Failure Vagal nerve stimulation activates vagal afferent fibers that reduce cardiac efferent parasympathetic effects.Utility of a Novel Biofeedback Device for Within-Breath Modulation of Heart Rate in Rats: A Quantitative Comparison of Vagus Nerve vs. Right Atrial Pacing.Modulation of heart rate by temporally patterned vagus nerve stimulation in the anesthetized dog Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning Innervation of the heart: An invisible grid within a black box.Autonomic Modulation in Heart Failure: Ready for Prime Time?Parasympathetic Vagal Control of Cardiac Function.Autonomic Modulation by Electrical Stimulation of the Parasympathetic Nervous System: An Emerging Intervention for Cardiovascular Diseases.Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis.Translational neurocardiology: preclinical models and cardioneural integrative aspects.Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies.Some Non-FDA Approved Uses for Neuromodulation in Treating Autonomic Nervous System Disorders: A Discussion of the Preliminary Support.NEUROMODULATION OF THE FAILING HEART: LOST IN TRANSLATION?Cardiac autonomic innervation.Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction.The last frontier: transcatheter devices for percutaneous or minimally invasive treatment of chronic heart failure.Device-based autonomic modulation in arrhythmia patients: the role of vagal nerve stimulation.'Runaway' vagal nerve stimulator: a case of cyclic asystole.Differential hemodynamic and respiratory responses to right and left cervical vagal nerve stimulation in rats.Muscarinic Stimulation Facilitates Sarcoplasmic Reticulum Ca Release by Modulating Ryanodine Receptor 2 Phosphorylation Through Protein Kinase G and Ca/Calmodulin-Dependent Protein Kinase II.Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment?Effects of yoga versus hydrotherapy training on health-related quality of life and exercise capacity in patients with heart failure: A randomized controlled study.Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics.A novel controller based on state-transition models for closed-loop vagus nerve stimulation: Application to heart rate regulation.Defining the neural fulcrum for chronic vagus nerve stimulation: implications for integrated cardiac control.Cardiovascular autonomic effects of vagus nerve stimulation.The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study.Short‑term vagus nerve stimulation reduces myocardial apoptosis by downregulating microRNA‑205 in rats with chronic heart failure.

P2860

Q27339391-A8CCDA85-0520-4B1D-98A7-E65C00B10472 Q28073923-F3FF9FBF-63C9-403F-AAB6-F4AF6FF386AA Q28075944-E78EB106-FB27-4CED-A3FA-CA34C8BB55AC Q30278548-E8AECDC2-1AAA-4FCF-9804-2879C1C6E016 Q33167779-A6FDB037-0802-477B-A7F5-2643556077E2 Q34477958-E1A16FE6-34AF-4675-8125-DF2D0649CC81 Q35215351-F6665EC3-E2EF-4101-8D46-6288EE7AC2CE Q35995878-BF696B11-098C-454A-873F-A542210C15FF Q36005022-B050D596-C87B-4FEA-84D3-20273F249076 Q36149948-84A7E713-FF0C-41D7-A4CA-6E148FA93F06 Q36165288-3C274744-BB0C-4B74-AB12-83FAAA3CE0D6 Q36339440-A3D6663F-0E46-4BA2-862E-FD723A0AE412 Q36541181-B53CC594-954D-47D7-90A0-263EEE5A40C4 Q36597681-13BCED27-F631-4845-9C71-689C1C374A6E Q37034247-268445C7-00C0-4439-80C6-C683EA1D8F52 Q38562977-E3B7E9FD-5CCF-40F0-905A-8C92373629A6 Q38588983-AB8960A2-9285-44A7-B75B-0CED72FCC280 Q38724274-F8405F9B-F01F-4540-917F-A1C0FEF07444 Q38749936-A817E7C3-40AD-4044-B695-324A0052A092 Q38761997-E2718928-1B9A-4174-948C-242B72725DC8 Q38813230-F369D801-709C-4C30-9903-16E7415578D8 Q38837789-F118EDE8-80AB-4E5E-98AD-38E49B659A1B Q38875511-27D49552-0E16-4A5E-8CCC-F328E986C816 Q38927895-A164FFA2-B57C-46FC-B13D-EA9119C42C34 Q39008890-28925362-C254-4ACA-BD8C-EFD641B1282D Q39454168-8B5CF5DB-D6FE-49D9-B618-B99461E63EC9 Q39456492-E1D5B300-A4DD-4B5D-AC20-E40593B04252 Q41933607-059AC8BE-ED54-46D2-B184-10911A99BAFA Q42196600-7EA28D56-4954-480C-9713-6437CC56A487 Q42291365-C14E016A-E6BF-4EA8-900F-3A9A209D9717 Q42702471-78BE70CF-5C50-42E5-ACCA-87536FB58CE1 Q43115758-6388BE0F-1830-44DA-9AAC-6602153AC7DB Q46122316-5E6742B3-EC14-4709-ABC1-6FEF0F53CB29 Q46336435-1DF6E65E-7C5D-416B-B594-C137CA84AA0E Q47105659-6C00BAB8-6FC4-40AC-85EA-00D4399705FF Q47257549-870A42C7-FE9B-4BB2-89B5-0B97E515A36D Q47409265-648FADD2-1583-42CB-B88F-F8FE9DCB765C Q47631903-03E82330-4A29-495E-8F0C-F0333DA7B9C1 Q47667565-284DAC6D-304B-4E87-9224-3706173054DA Q47891708-3C246D95-F756-4B5A-B83B-3F7D945CA3F0

P2860

Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial

http://www.wikidata.org/entity/Q35083803

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Chronic vagal stimulation for ...... F) randomized controlled trial

@ast

Chronic vagal stimulation for ...... F) randomized controlled trial

@en

type

label

Chronic vagal stimulation for ...... F) randomized controlled trial

@ast

Chronic vagal stimulation for ...... F) randomized controlled trial

@en

prefLabel

Chronic vagal stimulation for ...... F) randomized controlled trial

@ast

Chronic vagal stimulation for ...... F) randomized controlled trial

@en

P1433

Q35083803-D2FCB227-CB78-428A-9CDC-B84F7D276BE2

P1476

Q35083803-570DC27B-C4D3-4838-AFD4-80CBD5B23FA1

P2093

Q35083803-1339E4B4-9220-4A5B-ADE2-7F8F609C796A

Q35083803-1602EBD9-9B3E-40D8-9A5A-92566AD99B57

Q35083803-1E6E4D77-7DA6-4CA4-BF20-7FE9E77A9A79

Q35083803-281AA37F-217A-4884-BC36-0E0E21C98627

Q35083803-371BB849-6EFE-49F7-B78E-CA2E261E78C4

Q35083803-3EDEBAE1-9603-4579-94AB-B84C205BF990

Q35083803-46410881-46B3-4EDC-B68B-79C8C7C110CC

Q35083803-4E27FC2D-CCF4-49E1-8AE7-1FEDF430B781

Q35083803-52119788-05A2-4430-A8DB-9C7698CF5653

Q35083803-5C1C8930-9919-45A5-AAE8-4CA46FAC22A6

P2860

Q35083803-047C0825-CF2C-432C-B85D-2AF8190A0D8B

Q35083803-0539696B-6829-4D57-8F11-CF5560B6E2C0

Q35083803-18B5D2E8-3F1D-48FB-BE19-B8FEFD9A4AB1

Q35083803-1ECA04A2-61B2-42BB-86A7-D7ABD4B7C1DD

Q35083803-229D2D6F-E78B-4D7D-8EF8-BF889F3B1524

Q35083803-229F75A1-CEA1-4B38-BED0-42C3E06922C1

Q35083803-254D20EF-512C-4E0A-9AC9-0337B7D42645

Q35083803-28F5169C-A603-4434-A315-CB92CDD2A18D

Q35083803-39D88269-4EFB-49BC-9EE9-50C1C4E5E708

Q35083803-4B795BE9-08A2-47A4-A2B1-B14F80E51BC9

P304

Q35083803-B25A3CC9-8B5C-483F-8149-441773E7AA99

P31

Q35083803-73AF34A0-BECB-411D-9C7D-9DA27EE0D485

P356

Q35083803-65D4BA4D-2814-498A-9CAD-A8C941ED7A1D

P433

Q35083803-698C7190-1DEB-4DF4-8F46-0371D8C687F9

P478

Q35083803-8A6CC308-555F-48D4-A6A3-1D9C1D1483C0

P50

Q35083803-F7F11536-F469-44B9-92DE-1DDC8F843248

P577

Q35083803-F9DD1FEE-B2FA-43FD-8E7F-7A30D59A5EC1

P5875

Q35083803-B83BFD73-8BDE-4ED7-94CF-D37C230C36B9

P698

Q35083803-FEE3ED62-65C6-48AD-8C86-70A0BCE46921

P921

Q35083803-9C75FB02-7092-41B7-8430-BFD6E4C1DA6B

P932

Q35083803-D9701981-728E-4E31-ACE6-D125A96B0B0E

P356

P1433

European Heart Journal

P1476

Chronic vagal stimulation for ...... F) randomized controlled trial

@en

P2093

Agnes Ramuzat

http://www.w3.org/2001/XMLSchema#string

Anton E Tuinenburg

http://www.w3.org/2001/XMLSchema#string

Antonio D'Onofrio

http://www.w3.org/2001/XMLSchema#string

Bernd Schubert

http://www.w3.org/2001/XMLSchema#string

Christian Butter

http://www.w3.org/2001/XMLSchema#string

Cornelis Botman

http://www.w3.org/2001/XMLSchema#string

Craig Stolen

http://www.w3.org/2001/XMLSchema#string

David Wright

http://www.w3.org/2001/XMLSchema#string

Doug Daum

http://www.w3.org/2001/XMLSchema#string

Gaetano M De Ferrari

http://www.w3.org/2001/XMLSchema#string

P2860

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation

Reflex principles of immunological homeostasis

A controlled trial of renal denervation for resistant hypertension

Reflex control of immunity

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

The inflammatory reflex.

Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF.

Pharmacological stimulation of the cholinergic antiinflammatory pathway.

Vagus nerve stimulation in experimental heart failure.

Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure.

P304

425-433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHU345

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265214398

http://www.w3.org/2001/XMLSchema#string

P698

25176942

http://www.w3.org/2001/XMLSchema#string

P921

P932

4328197

http://www.w3.org/2001/XMLSchema#string